HaHafeng
3634933ece
- feat: Create ASLLayout component with 7-module left navigation - feat: Implement Title Screening Settings page with optimized PICOS layout - feat: Add placeholder pages for Workbench and Results - fix: Fix nested routing structure for React Router v6 - fix: Resolve Spin component warning in MainLayout - fix: Add QueryClientProvider to App.tsx - style: Optimize PICOS form layout (P+I left, C+O+S right) - style: Align Inclusion/Exclusion criteria side-by-side - docs: Add architecture refactoring and routing fix reports Ref: Week 2 Frontend Development Scope: ASL module MVP - Title Abstract Screening
150 lines
4.4 KiB
JSON
150 lines
4.4 KiB
JSON
{
|
|
"metrics": {
|
|
"totalTests": 10,
|
|
"correctDecisions": 0,
|
|
"accuracy": 0,
|
|
"consistencyRate": 0,
|
|
"jsonValidRate": 1,
|
|
"avgConfidence": 0,
|
|
"needReviewRate": 1,
|
|
"confusionMatrix": {
|
|
"truePositive": 0,
|
|
"falsePositive": 0,
|
|
"trueNegative": 0,
|
|
"falseNegative": 0,
|
|
"uncertain": 0
|
|
}
|
|
},
|
|
"results": [
|
|
{
|
|
"literatureId": "test-001",
|
|
"title": "Efficacy and Safety of Empagliflozin in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial",
|
|
"expectedDecision": "include",
|
|
"actualDecision": "error",
|
|
"isCorrect": false,
|
|
"hasConsensus": false,
|
|
"needReview": true,
|
|
"avgConfidence": 0,
|
|
"deepseekResult": null,
|
|
"qwenResult": null,
|
|
"processingTime": 6
|
|
},
|
|
{
|
|
"literatureId": "test-002",
|
|
"title": "Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes",
|
|
"expectedDecision": "include",
|
|
"actualDecision": "error",
|
|
"isCorrect": false,
|
|
"hasConsensus": false,
|
|
"needReview": true,
|
|
"avgConfidence": 0,
|
|
"deepseekResult": null,
|
|
"qwenResult": null,
|
|
"processingTime": 1
|
|
},
|
|
{
|
|
"literatureId": "test-003",
|
|
"title": "Systematic Review and Meta-Analysis of SGLT2 Inhibitors in Type 2 Diabetes: A Comprehensive Assessment",
|
|
"expectedDecision": "exclude",
|
|
"actualDecision": "error",
|
|
"isCorrect": false,
|
|
"hasConsensus": false,
|
|
"needReview": true,
|
|
"avgConfidence": 0,
|
|
"deepseekResult": null,
|
|
"qwenResult": null,
|
|
"processingTime": 1
|
|
},
|
|
{
|
|
"literatureId": "test-004",
|
|
"title": "Dapagliflozin Improves Cardiac Function in Diabetic Rats: An Experimental Study",
|
|
"expectedDecision": "exclude",
|
|
"actualDecision": "error",
|
|
"isCorrect": false,
|
|
"hasConsensus": false,
|
|
"needReview": true,
|
|
"avgConfidence": 0,
|
|
"deepseekResult": null,
|
|
"qwenResult": null,
|
|
"processingTime": 0
|
|
},
|
|
{
|
|
"literatureId": "test-005",
|
|
"title": "Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy",
|
|
"expectedDecision": "include",
|
|
"actualDecision": "error",
|
|
"isCorrect": false,
|
|
"hasConsensus": false,
|
|
"needReview": true,
|
|
"avgConfidence": 0,
|
|
"deepseekResult": null,
|
|
"qwenResult": null,
|
|
"processingTime": 0
|
|
},
|
|
{
|
|
"literatureId": "test-006",
|
|
"title": "Real-World Experience with SGLT2 Inhibitors: A Retrospective Cohort Study",
|
|
"expectedDecision": "exclude",
|
|
"actualDecision": "error",
|
|
"isCorrect": false,
|
|
"hasConsensus": false,
|
|
"needReview": true,
|
|
"avgConfidence": 0,
|
|
"deepseekResult": null,
|
|
"qwenResult": null,
|
|
"processingTime": 1
|
|
},
|
|
{
|
|
"literatureId": "test-007",
|
|
"title": "Pharmacokinetics and Pharmacodynamics of Empagliflozin in Healthy Volunteers",
|
|
"expectedDecision": "exclude",
|
|
"actualDecision": "error",
|
|
"isCorrect": false,
|
|
"hasConsensus": false,
|
|
"needReview": true,
|
|
"avgConfidence": 0,
|
|
"deepseekResult": null,
|
|
"qwenResult": null,
|
|
"processingTime": 0
|
|
},
|
|
{
|
|
"literatureId": "test-008",
|
|
"title": "Comparative Effectiveness of SGLT2 Inhibitors versus DPP-4 Inhibitors in Elderly Patients with Type 2 Diabetes",
|
|
"expectedDecision": "exclude",
|
|
"actualDecision": "error",
|
|
"isCorrect": false,
|
|
"hasConsensus": false,
|
|
"needReview": true,
|
|
"avgConfidence": 0,
|
|
"deepseekResult": null,
|
|
"qwenResult": null,
|
|
"processingTime": 0
|
|
},
|
|
{
|
|
"literatureId": "test-009",
|
|
"title": "Severe Diabetic Ketoacidosis Associated with SGLT2 Inhibitor Use: A Case Report",
|
|
"expectedDecision": "exclude",
|
|
"actualDecision": "error",
|
|
"isCorrect": false,
|
|
"hasConsensus": false,
|
|
"needReview": true,
|
|
"avgConfidence": 0,
|
|
"deepseekResult": null,
|
|
"qwenResult": null,
|
|
"processingTime": 1
|
|
},
|
|
{
|
|
"literatureId": "test-010",
|
|
"title": "Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Moderate Renal Impairment",
|
|
"expectedDecision": "uncertain",
|
|
"actualDecision": "error",
|
|
"isCorrect": false,
|
|
"hasConsensus": false,
|
|
"needReview": true,
|
|
"avgConfidence": 0,
|
|
"deepseekResult": null,
|
|
"qwenResult": null,
|
|
"processingTime": 0
|
|
}
|
|
]
|
|
} |